Meta-analysis assessing the effectiveness of SGLT2i+GLP1RA combination therapy versus monotherapy on cardiovascular and cerebrovascular outcomes in diabetic patients

Relevant meta-analyses have confirmed the cardiovascular and renal benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) among patients with type 2 diabetes (T2D) and/or cardiorenal disease. However, it is not established whether the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lixin, Qin, Jiao, Wang, Dengchuan, Zhao, Yunhui, Xu, Ning, Wu, Chaowen, Yuan, Jianpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Physiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676496/
https://www.ncbi.nlm.nih.gov/pubmed/36419835
http://dx.doi.org/10.3389/fphys.2022.1028486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676496/
https://www.ncbi.nlm.nih.gov/pubmed/36419835
http://dx.doi.org/10.3389/fphys.2022.1028486

Ejemplares similares